Nano- and micro-launches are the new normal, but what indicates blockbuster potential?
The majority of biopharma launches aren't blockbuster products. We take a look at the factors that signal blockbuster potential.
The majority of biopharma launches aren't blockbuster products. We take a look at the factors that signal blockbuster potential.